🇺🇸 ginkgolide in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Granulocytopenia — 2 reports (16.67%)
  2. Thrombocytopenia — 2 reports (16.67%)
  3. Acute Respiratory Failure — 1 report (8.33%)
  4. Arteriosclerosis — 1 report (8.33%)
  5. Carotid Artery Stenosis — 1 report (8.33%)
  6. Cerebral Arteriosclerosis — 1 report (8.33%)
  7. Cerebral Infarction — 1 report (8.33%)
  8. Condition Aggravated — 1 report (8.33%)
  9. Demyelination — 1 report (8.33%)
  10. Drooling — 1 report (8.33%)

Source database →

Other Other approved in United States

Frequently asked questions

Is ginkgolide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ginkgolide in United States?

Second Affiliated Hospital, School of Medicine, Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.